Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis

According to statistics, infectious and inflammatory eye diseases of various etiologies are widespread in the world (about 18 million cases per year). In some cases, they are severe and can lead to a decrease in acuity and even loss of vision. About 12 million in the structure of infectious and infl...

Full description

Bibliographic Details
Main Authors: N. G. Zumbulidze, V. M. Khokkanen, I. B. Litvin
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2023-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/1999
_version_ 1797875354828800000
author N. G. Zumbulidze
V. M. Khokkanen
I. B. Litvin
author_facet N. G. Zumbulidze
V. M. Khokkanen
I. B. Litvin
author_sort N. G. Zumbulidze
collection DOAJ
description According to statistics, infectious and inflammatory eye diseases of various etiologies are widespread in the world (about 18 million cases per year). In some cases, they are severe and can lead to a decrease in acuity and even loss of vision. About 12 million in the structure of infectious and inflammatory diseases of the eye are conjunctivitis, which may be accompanied by inflammation of the edges of the eyelids (blepharoconjunctivitis) and / or the cornea (keratoconjunctivitis). A viral infection is one of the common causes of inflammation of the mucous membrane of the eyes. In the routine practice of ophthalmologists, adeno- and herpesvirus lesions of the organ of vision are most often diagnosed. Eye diseases of herpetic etiology are among the most common infections. Herpetic conjunctivitis usually develops as a result of an initial attack by Herpes simplex virus type 1 (HSV-1) in early childhood. But there is reason to believe that in adults they are no less common than herpetic keratitis, however, the diagnosis of isolated herpetic conjunctivitis is extremely rare, since, unlike herpetic keratitis or creatoconjunctivitis, the clinic is less pronounced, not always confirmed by laboratory, which leads to underdiagnosis. During the treatment of ophthalmic herpes, one should rely not only on the antiviral effect of drugs, but also on the presence of immunomodulators (interferons or inducers of endogenous interferonogenesis) in the complex therapy, which contribute to faster recovery with fewer relapses.The aim of this study was to evaluate the effectiveness of the use of the drug OCTALMOL in the treatment of 34 patients with conjunctivitis and keratitis of herpesvirus etiology. The drug contributed to the relief of clinical symptoms of inflammation and a reduction in the duration of therapy in 89 % of patients, while the average duration of treatment was 10.7 ± 0.3 days. The therapeutic effect in the group where OCTALMOL was included in the basic therapy was statistically higher than in the control group.
first_indexed 2024-04-10T01:45:15Z
format Article
id doaj.art-16a49de5a97b47c3b183d37dce43b853
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2024-04-10T01:45:15Z
publishDate 2023-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-16a49de5a97b47c3b183d37dce43b8532023-03-13T09:08:44ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452023-01-0119486487410.18008/1816-5095-2022-4-864-874984Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and KeratitisN. G. Zumbulidze0V. M. Khokkanen1I. B. Litvin2ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Министерства здравоохранения Российской ФедерацииAccording to statistics, infectious and inflammatory eye diseases of various etiologies are widespread in the world (about 18 million cases per year). In some cases, they are severe and can lead to a decrease in acuity and even loss of vision. About 12 million in the structure of infectious and inflammatory diseases of the eye are conjunctivitis, which may be accompanied by inflammation of the edges of the eyelids (blepharoconjunctivitis) and / or the cornea (keratoconjunctivitis). A viral infection is one of the common causes of inflammation of the mucous membrane of the eyes. In the routine practice of ophthalmologists, adeno- and herpesvirus lesions of the organ of vision are most often diagnosed. Eye diseases of herpetic etiology are among the most common infections. Herpetic conjunctivitis usually develops as a result of an initial attack by Herpes simplex virus type 1 (HSV-1) in early childhood. But there is reason to believe that in adults they are no less common than herpetic keratitis, however, the diagnosis of isolated herpetic conjunctivitis is extremely rare, since, unlike herpetic keratitis or creatoconjunctivitis, the clinic is less pronounced, not always confirmed by laboratory, which leads to underdiagnosis. During the treatment of ophthalmic herpes, one should rely not only on the antiviral effect of drugs, but also on the presence of immunomodulators (interferons or inducers of endogenous interferonogenesis) in the complex therapy, which contribute to faster recovery with fewer relapses.The aim of this study was to evaluate the effectiveness of the use of the drug OCTALMOL in the treatment of 34 patients with conjunctivitis and keratitis of herpesvirus etiology. The drug contributed to the relief of clinical symptoms of inflammation and a reduction in the duration of therapy in 89 % of patients, while the average duration of treatment was 10.7 ± 0.3 days. The therapeutic effect in the group where OCTALMOL was included in the basic therapy was statistically higher than in the control group.https://www.ophthalmojournal.com/opht/article/view/1999герпетическийаденовирусный конъюнктивиткератитконъюнктиваотекхемозгиперемияфолликулыиммуномодуляторинтерферонпарааминобензойная кислотавпг-1herpes simplex
spellingShingle N. G. Zumbulidze
V. M. Khokkanen
I. B. Litvin
Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
Oftalʹmologiâ
герпетический
аденовирусный конъюнктивит
кератит
конъюнктива
отек
хемоз
гиперемия
фолликулы
иммуномодулятор
интерферон
парааминобензойная кислота
впг-1
herpes simplex
title Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
title_full Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
title_fullStr Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
title_full_unstemmed Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
title_short Experience in the Use and Evaluation of the Therapeutic Efficacy of a Drug Based on Para-Aminobenzoic Acid in the Complex Therapy of Herpesvirus Conjunctivitis and Keratitis
title_sort experience in the use and evaluation of the therapeutic efficacy of a drug based on para aminobenzoic acid in the complex therapy of herpesvirus conjunctivitis and keratitis
topic герпетический
аденовирусный конъюнктивит
кератит
конъюнктива
отек
хемоз
гиперемия
фолликулы
иммуномодулятор
интерферон
парааминобензойная кислота
впг-1
herpes simplex
url https://www.ophthalmojournal.com/opht/article/view/1999
work_keys_str_mv AT ngzumbulidze experienceintheuseandevaluationofthetherapeuticefficacyofadrugbasedonparaaminobenzoicacidinthecomplextherapyofherpesvirusconjunctivitisandkeratitis
AT vmkhokkanen experienceintheuseandevaluationofthetherapeuticefficacyofadrugbasedonparaaminobenzoicacidinthecomplextherapyofherpesvirusconjunctivitisandkeratitis
AT iblitvin experienceintheuseandevaluationofthetherapeuticefficacyofadrugbasedonparaaminobenzoicacidinthecomplextherapyofherpesvirusconjunctivitisandkeratitis